Ranitidine recall affects Australia

Move is part of global recalls following contamination concerns, says Novartis AG’s Sandoz division

A manufacturer of generic ranitidine is recalling multiple batches of film-coated tablets in Australia, after some tablets were found to be contaminated by a probable carcinogen.